A detailed history of Horizons Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Horizons Wealth Management holds 338 shares of LLY stock, worth $266,790. This represents 0.23% of its overall portfolio holdings.

Number of Shares
338
Previous 338 -0.0%
Holding current value
$266,790
Previous $306,000 2.29%
% of portfolio
0.23%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 05, 2024

BUY
$525.19 - $619.13 $172,787 - $203,693
329 Added 3655.56%
338 $197,000
Q2 2023

Jul 03, 2023

BUY
$350.74 - $468.98 $3,156 - $4,220
9 New
9 $4,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Horizons Wealth Management Portfolio

Follow Horizons Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizons Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Horizons Wealth Management with notifications on news.